C2I Trademark

Trademark Overview


On Tuesday, June 9, 2020, a trademark application was filed for C2I with the United States Patent and Trademark Office. The USPTO has given the C2I trademark a serial number of 88956256. The federal status of this trademark filing is REGISTERED as of Tuesday, February 27, 2024. This trademark is owned by C2i Genomics, Inc.. The C2I trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software-as-a-Service (SaaS) services featuring software and Platform-as-a-Service (PaaS) services feature computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based software, all for accessing cloud-based servers and remote client servers for measuring post-surgical cancer burden scores through bioinformatics and artificial intelligence, analyzing genetic patterns post-surgery, providing medical and cancer treatment recommendation, and providing cancer and medical treatment monitoring throughout the patient cancer encounter for use by health systems, oncologists, physicians, cancer clinics, medical professionals, and hospitals
c2i

General Information


Serial Number88956256
Word MarkC2I
Filing DateTuesday, June 9, 2020
Status700 - REGISTERED
Status DateTuesday, February 27, 2024
Registration Number7316540
Registration DateTuesday, February 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements


Pseudo MarkC TWO I
Goods and ServicesSoftware-as-a-Service (SaaS) services featuring software and Platform-as-a-Service (PaaS) services feature computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based software, all for accessing cloud-based servers and remote client servers for measuring post-surgical cancer burden scores through bioinformatics and artificial intelligence, analyzing genetic patterns post-surgery, providing medical and cancer treatment recommendation, and providing cancer and medical treatment monitoring throughout the patient cancer encounter for use by health systems, oncologists, physicians, cancer clinics, medical professionals, and hospitals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 6, 2020
Primary Code042
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

Trademark Owner History


Party NameVERACYTE DIAGNOSTICS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10014

Party NameC2i Genomics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameC2i Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameC2i Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events


Event DateEvent Description
Friday, June 12, 2020NEW APPLICATION ENTERED
Monday, July 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 11, 2020ASSIGNED TO EXAMINER
Tuesday, September 15, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 15, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, September 15, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 15, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, September 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 14, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 14, 2021SOU EXTENSION 1 FILED
Monday, June 14, 2021SOU EXTENSION 1 GRANTED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021SOU EXTENSION 2 FILED
Tuesday, November 23, 2021SOU EXTENSION 2 GRANTED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 13, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 13, 2022SOU EXTENSION 3 FILED
Monday, June 13, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 7, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 7, 2022SOU EXTENSION 4 FILED
Wednesday, December 7, 2022SOU EXTENSION 4 GRANTED
Friday, December 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2023SOU EXTENSION 5 FILED
Wednesday, May 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 31, 2023SOU EXTENSION 5 GRANTED
Thursday, June 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, January 20, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 14, 2023USE AMENDMENT FILED
Saturday, December 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, January 19, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, July 11, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED